TITAN PHARMACEUTICALS INC — Investor Relations & Filings
Filings indexed
1,000
across all filing types
Latest filing
2013-08-14
Interim / Quarterly Rep…
Country
US
United States of America
Listing
US
TTNP
Titan Pharmaceuticals, Inc. is a development-stage biopharmaceutical company that develops proprietary therapeutics using its clinically proven ProNeura® technology, a long-term, continuous drug delivery platform. This platform is designed for the administration of medicines to treat select chronic diseases. The ProNeura system involves a small, solid implant that is placed subdermally and provides continuous, non-fluctuating blood levels of a drug for an extended period. The company's development efforts have historically focused on treatments for central nervous system disorders.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 10-Q | 2013-08-14 | English | |
| Regulatory Filings 2013 | 2013-08-02 | English | |
| Regulatory Filings 2013 | 2013-08-01 | English | |
| AMENDMENT NO. 1 TO FORM 10-K | 2013-07-23 | English | |
| Regulatory Filings 2013 | 2013-07-22 | English | |
| 8-K | 2013-07-05 | English |
Browse filings by year
27 years- 2025 42 filings
- 2024 24 filings
- 2023 51 filings
- 2022 52 filings
- 2021 37 filings
- 2020 73 filings
- 2019 60 filings
- 2018 52 filings
- 2017 40 filings
- 2016 36 filings
- 2015 51 filings
- 2014 29 filings
- 2013 34 filings
- 2012 30 filings
- 2011 36 filings
- 2010 39 filings
- 2009 3 filings
- 2008 53 filings
- 2007 45 filings
- 2006 40 filings
- 2005 42 filings
- 2004 44 filings
- 2003 30 filings
- 2002 20 filings
- 2001 12 filings
- 2000 13 filings
- 1999 12 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2013
15 filings
| |||||
| 10052321 | FORM 10-Q | 2013-08-14 | English | ||
| 10052322 | Regulatory Filings 2013 | 2013-08-02 | English | ||
| 10052323 | Regulatory Filings 2013 | 2013-08-01 | English | ||
| 10052325 | AMENDMENT NO. 1 TO FORM 10-K | 2013-07-23 | English | ||
| 10052324 | Regulatory Filings 2013 | 2013-07-22 | English | ||
| 10052326 | 8-K | 2013-07-05 | English | ||
| 10052327 | FORM 4 | 2013-06-19 | English | ||
| 10052328 | FORM 4 | 2013-06-19 | English | ||
| 10052329 | Major Shareholding Notification 2013 | 2013-06-07 | English | ||
| 10052330 | 8-A12G | 2013-05-29 | English | ||
| 10052331 | FORM 8-K | 2013-05-29 | English | ||
| 10052333 | FORM 10-Q | 2013-05-15 | English | ||
| 10052334 | FORM 8-K | 2013-05-01 | English | ||
| 10052335 | FORM 8-K | 2013-03-22 | English | ||
| 10052336 | FORM 10-K | 2013-03-18 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
TITAN PHARMACEUTICALS INC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35418/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35418 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35418 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35418 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35418}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for TITAN PHARMACEUTICALS INC (id: 35418)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.